Pharmacy Certification · BCIDP

BPS Infectious Diseases Pharmacy Certification Examination Practice Test

Infectious diseases pharmacy practice requires interpreting microbiology results and matching antimicrobial therapy to the patient, organism, infection site, and clinical response. BCIDP practice questions sample decisions involving bloodstream infections, endocarditis, Clostridioides difficile, HIV-related opportunistic infection prevention, antimicrobial adverse effects, and drug interactions.

Exam overview

Exam providerBoard of Pharmacy Specialties
Exam codeBCIDP
CategoryPharmacy Certification

About the BPS Infectious Diseases Pharmacy Certification Examination Exam

Clinical reasoning in infectious diseases pharmacy includes distinguishing likely pathogens from contaminants, applying susceptibility results, and evaluating factors that affect antimicrobial selection and treatment duration. Patient-specific decisions may involve allergy history, renal function, toxicity monitoring, pharmacokinetic principles such as aminoglycoside extended-interval dosing, and interactions that alter drug exposure. Other scenarios address treatment approaches for severe infection, including fulminant C. difficile disease, and preventive therapy such as Pneumocystis jirovecii pneumonia prophylaxis in people with HIV. These questions also connect medication knowledge with practical tasks: assessing the significance of culture findings, identifying emerging toxicity, and adjusting or recommending therapy as clinical circumstances change.

Sample Practice Questions

Review a selection from this exam's published US Practice Tests practice bank.

Question 1

A hospitalized patient has a positive blood culture for coagulase-negative staphylococci in only one of several sets and no intravascular device or compatible symptoms. What is an appropriate initial interpretation?

  1. APossible blood-culture contamination that should be assessed in clinical context
  2. BDefinite endocarditis requiring a prolonged course of therapy
  3. CProof of a deep-seated infection regardless of the clinical picture
  4. DA result that can never represent true infection
Show answerCorrect answer: A

Coagulase-negative staphylococci commonly contaminate blood cultures but can cause true infection, especially with intravascular devices or prosthetic material. Interpret the number and pattern of positive cultures alongside symptoms and risk factors.

Question 2

A patient with suspected Clostridioides difficile infection develops hypotension and ileus. Which treatment approach is generally appropriate for fulminant disease?

  1. AOral or enteral vancomycin with intravenous metronidazole, with rectal vancomycin considered if ileus limits delivery
  2. BOral vancomycin alone at a routine nonsevere-disease regimen, regardless of ileus
  3. CIntravenous vancomycin alone
  4. DLoperamide as sole therapy
Show answerCorrect answer: A

Fulminant C. difficile infection is generally treated with high-dose enteral vancomycin plus intravenous metronidazole. Rectal vancomycin may be considered when ileus impairs delivery to the colon; urgent supportive care and specialist assessment are also important.

Question 3

A patient receiving an aminoglycoside for a serious infection develops a rising serum creatinine. Which toxicity is most directly suggested by this finding?

  1. ANephrotoxicity
  2. BRetinal toxicity
  3. CPancreatitis
  4. DTendon rupture
Show answerCorrect answer: A

Aminoglycosides can cause kidney injury, and a rising creatinine warrants prompt assessment of renal function, dose and interval, drug exposure, and other nephrotoxic medications.

Question 4

A patient with a documented immediate anaphylactic reaction to penicillin needs treatment for an infection. Which detail is most useful when assessing whether a cephalosporin might be an option?

  1. AWhether the cephalosporin has a related side chain to the culprit penicillin
  2. BWhether the patient has ever taken an antifungal drug
  3. CThe color of the prior penicillin tablet
  4. DWhether the infection is community acquired
Show answerCorrect answer: A

Beta-lactam cross-reactivity is influenced substantially by structural similarity, especially side chains. The reaction history, culprit drug, and urgency should inform individualized allergy assessment and selection.

Question 5

A patient receiving prolonged linezolid therapy develops new numbness and tingling in both feet. Which adverse effect should be considered?

  1. APeripheral neuropathy
  2. BAchilles tendon rupture
  3. CNephrolithiasis
  4. DOtotoxicity
Show answerCorrect answer: A

Prolonged linezolid exposure can cause peripheral and optic neuropathy. New sensory symptoms warrant clinical assessment and review of treatment duration and alternatives.

Question 6

A patient taking an oral medication with substantial hepatic metabolism is prescribed clarithromycin. What interaction mechanism should a pharmacist consider?

  1. AInhibition of CYP3A4 may increase concentrations of some concomitant drugs
  2. BInduction of CYP3A4 may rapidly lower concentrations of all concomitant drugs
  3. CChelation of concomitant drugs in the stomach is expected
  4. DInhibition of renal tubular secretion is universal
Show answerCorrect answer: A

Clarithromycin inhibits CYP3A4 and can raise exposure to susceptible substrates. Review the medication list for clinically important interactions and consider an alternative antimicrobial or adjustment and monitoring when appropriate.

Question 7

A patient with infective endocarditis caused by viridans group streptococci has a penicillin-susceptible isolate. Which factor is important when selecting the duration and regimen of therapy?

  1. AWhether the patient has a prosthetic valve or native valve, along with susceptibility results
  2. BThe patient's serum potassium concentration alone
  3. CWhether the isolate is resistant to vancomycin, regardless of penicillin susceptibility
  4. DThe presence of a cough at the time of diagnosis
Show answerCorrect answer: A

Endocarditis treatment selection and duration depend on factors including the organism's susceptibility, whether the valve is native or prosthetic, and clinical features. These factors help determine the appropriate regimen; potassium or cough alone does not.

How to use this practice test

Access is free. The practice session draws up to 20 random questions from the 50-question bank and displays results after submission. Use the scenarios to identify which clinical detail drives each decision, then review missed concepts such as culture interpretation, toxicity, antimicrobial selection, and prophylaxis.

Preparation tips

  • For blood-culture scenarios, compare the organism, number of positive sets, symptoms, and presence of intravascular devices before judging contamination versus infection.
  • Review treatment considerations for severe or fulminant C. difficile infection, including how hypotension and ileus affect the clinical approach.
  • Connect antimicrobial toxicities with monitoring findings, such as rising creatinine during aminoglycoside therapy and peripheral neuropathy during prolonged linezolid use.
  • Practice evaluating beta-lactam allergy histories and drug-interaction mechanisms, including how clarithromycin can affect medicines metabolized through hepatic pathways.
  • Review prophylaxis decisions in HIV using CD4 count and recognize the role of trimethoprim-sulfamethoxazole in preventing Pneumocystis jirovecii pneumonia.
Official sourceOfficial exam page ↗Official exam guide ↗